CNR2 and neoplasm: Δ9-THC (8 μM) and JWH-015 (8 μM) (synthetic CB2 agonist) diminished ascites’ development in an orthotopic model of hepatocellular carcinoma (HCC) and also reduced the growth of HepG2 and HuH-7-derived tumor xenografts.